MaxCyte
Biotechnology Research • 
Rockville, Maryland, United States • 101-200 Employees
Company overview
| Headquarters | 9713 Key West Ave, Suite 400, Rockville, Maryland 20850, US |
| Phone number | +13019441700 |
| Website | |
| SIC | 283 |
| Keywords | Biotechnology, Gene Therapy, Life Sciences, Cancer, Innovation, Immunotherapy, Cancer Research, Cell Therapy, Stem Cell, Transfection, Carma, Immuno-Oncology, Vaccine Development, Electroporation, Cell Engineering, Protein Production, Gene Editing, Bispecifics, Myexpertplatform, Nkcell, Tcell |
| Founded | 1999 |
| Employees | 101-200 |
| Socials |
Key Contacts at MaxCyte
Daniel Nguyen
Director, Global Sales Enablement & Inside Sales
Grace Tharmarajah
Senior Director, Product Management
Sean Menarguez
Sr. Director, Innovation And Business Development
Andrew Guy Mancini
Director, Corporate Development
Joseph Abad
Senior Director, Process Development And Innovation
John Johnston
Non Executive Director
Richard Douglas
Board Of Directors
Gary Boch
Director Of Market Development
Crystal Kirk
Director Of Accounting
Marina Prasek
Director Project Management
MaxCyte Email Formats
MaxCyte uses 5 email formats. The most common is {first initial}{last name} (e.g., jdoe@maxcyte.com), used 47.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@maxcyte.com | 61.8% |
{first name}{last name} | johndoe@maxcyte.com | 26.8% |
{last name}{last name} | doedoe@maxcyte.com | 8.2% |
{first initial}{second initial}{last name} | jodoe@maxcyte.com | 1% |
About MaxCyte
We invest in our partners early on, working side by side in optimizing their processes to derisk their path to the clinic faster. Our ExPERT™ platform, which is based on our Flow Electroporation® technology, has been designed to support the rapidly expanding cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family of products includes: four instruments, the ATx™, STx™, GTx™ and VLx ™; a portfolio of proprietary related processing assemblies or disposables; and software protocols, all supported by a robust worldwide intellectual property portfolio. By providing our partners with the right technology, as well as technical and regulatory support, we aim to guide them on their journey to transform human health.
MaxCyte revenue & valuation
| Annual revenue | $35,800,000 |
| Revenue per employee | $280,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $114,500,000 |
| Total funding | $1,700,000 |
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
MaxCyte has 60 employees across 13 departments.
Departments
Number of employees
MaxCyte Tech Stack
Discover the technologies and tools that power MaxCyte's digital infrastructure, from frameworks to analytics platforms.
Security
Marketing automation
Form builders
Video players
Caching
Cookie compliance
Analytics
Maps
WordPress plugins
JavaScript libraries
CDN
Marketing automation
Australia
JapanFrequently asked questions
4.8
40,000 users
